An applicant for a cancer research grant shall:

1. A. Submit a completed application to the CCPC by the due date listed in the application packet; and

2. B. Include in the application packet the following information as specified in the Department’s application packet:

   1. (1) An executive summary stating:

      1. (a) How the grant funds will be used;
      2. (b) What institutions and other persons will be involved in the research;
      3. (c) Whether basic, clinical, applied, translational, or community-based research is being proposed;
      4. (d) Whether the proposed research is included in a recommendation of the Maryland Comprehensive Cancer Control Plan; and
      5. (e) How the grant money is expected to further the knowledge of cancer;

   2. (2) A statement of the need for the cancer research, including:

      1. (a) Previous literature in the area; and
      2. (b) Any work that the applicant has done in the research area;

   3. (3) A proposed cancer research plan describing:

      1. (a) How the grant funds will be used;
      2. (b) Who will be involved in the research;
      3. (c) What the anticipated results of the research with the grant funds will be; and
      4. (d) What goals, objectives, and activities will be pursued with the grant funds;

   4. (4) A brief professional resume or curriculum vitae of:

      1. (a) The principal investigator; and
      2. (b) Other key staff;
   5. (5) A description of how the proposed research will help to eliminate disparities between racial and ethnic minorities and the white population;

   6. (6) A list of the institutional review boards to which the research will be submitted for review and approval before the research is initiated, including the:

      1. (a) Department's Institutional Review Board; and
      2. (b) Applicant's relevant institutional review board;

   7. (7) A timeline showing the expected start date and completion date for each activity to be conducted under the grant, including application to and approval from the:

      1. (a) Department's Institutional Review Board; and
      2. (b) Applicant's relevant institutional review board;
   8. (8) An organizational chart showing where the work under the research grant is located within the applicant's organization;

   9. (9) A statement that the grant funds will not be used to supplant any existing funding for this cancer research and, if an applicant receives funding for a similar cancer research activity, a listing of the funding:

      1. (a) Source;
      2. (b) Amount; and
      3. (c) Period for the activity;
   10. (10) A line item budget for the cancer research grant; and
   11. (11) A written budget justification for each line item request.

Authority: Health-General Article, §20-117; Tax-General Article, §2-112; Annotated Code of Maryland

Effective date:

Regulations .01 — .16 adopted as an emergency provision effective June 1, 2006 (33:15 Md. R. 1274); adopted permanently effective October 9, 2006 (33:20 Md. R. 1616)

Regulation .02B amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)

Regulation .02B amended as an emergency provision effective December 22, 2008 (36:2 Md. R. 97); amended permanently effective April 6, 2009 (36:7 Md. R. 524)

Regulation .02B amended effective March 18, 2013 (40:5 Md. R. 411)

Regulation .02B amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)

Regulation .03A amended effective March 18, 2013 (40:5 Md. R. 411)

Regulation .05C amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)

Regulation .07 amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)

Regulation .08 amended effective October 4, 2010 (37:20 Md. R. 1393); March 18, 2013 (40:5 Md. R. 411)

Regulation .08 amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)

Regulation .08D, E amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)

Regulation .09 amended effective March 18, 2013 (40:5 Md. R. 411)

Regulation .10A amended effective March 18, 2013 (40:5 Md. R. 411)

Regulation .11 amended effective March 18, 2013 (40:5 Md. R. 411)

Regulation .12 amended effective March 18, 2013 (40:5 Md. R. 411)

Regulation .13 amended effective March 18, 2013 (40:5 Md. R. 411)

Regulation .14 amended effective March 18, 2013 (40:5 Md. R. 411)

Regulation .14C, D amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)

Regulation .14D, E amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)

Regulation .15 amended effective March 18, 2013 (40:5 Md. R. 411)

Regulation .15B amended as an emergency provision effective June 12, 2008 (35:14 Md. R. 1243); amended permanently effective October 20, 2008 (35:21 Md. R. 1824)

Regulation .16C amended effective March 18, 2013 (40:5 Md. R. 411)

Regulation .16C amended as an emergency provision effective January 1, 2014 (41:2 Md. R. 88); amended permanently effective May 12, 2014 (41:9 Md. R. 521)

Regulation .16D amended effective October 4, 2010 (37:20 Md. R. 1393)